SCHEMBL30837816

SCHEMBL30837816

COc1ccc(Cn2c(=O)c3cc(OC(CF)CF)ccc3n(C3CCN(C=O)CC3)c2=O)cc1F

nearest known ligand 0.88

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDE7A Q13946 10/20 0.88
PDE7B Q9NP56 5/20 0.88
PDE8A O60658 3/20 0.88
PDE5A O76074 2/20 0.37
PDE1B Q01064 1/20 0.37
MEN1 O00255 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
KMT2A Q03164 1/20 0.36
OPRM1 P35372 2/20 0.35
OPRL1 P41146 2/20 0.35
C5AR1 P21730 2/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
ALDH1A1 P00352 1/20 0.35
POLB P06746 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL100723 1.00 PDE7A (0.88) PDE7APDE7BPDE8APDE5APDE1B
SCHEMBL99921 0.94 PDE7A (0.88) PDE7APDE7BPDE8AMEN1GAA
SCHEMBL100704 0.94 PDE7A (1.00) PDE7APDE7BPDE8AMEN1GAA
SCHEMBL30837881 0.94 PDE7A (1.00) PDE7APDE7BPDE8AMEN1GAA
SCHEMBL99882 0.92 PDE7A (0.88) PDE7APDE7BPDE8AMEN1GAA
SCHEMBL30837836 0.92 PDE7A (0.88) PDE7APDE7BPDE8AMEN1GAA
SCHEMBL100702 0.92 PDE7A (0.87) PDE7APDE7BPDE8APDE5APDE1B
SCHEMBL100710 0.92 PDE7A (0.87) PDE7APDE7BPDE8AMEN1GAA
SCHEMBL100878 0.92 PDE7A (0.93) PDE7APDE7BPDE8AMEN1GAA
SCHEMBL30837796 0.92 PDE7A (0.93) PDE7APDE7BPDE8AMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4572765-A1 USE OF A THERAPEUTIC AGENT WITH PHOSPHODIESTERASE-7 INHIBITORY ACTIVITY FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH CHRONIC FATIGUE, EXHAUSTION AND/OR EXERTIONAL INTOLERANCE Mitodicure GmbH (DE) 2025-06-25 EP disclosed
WO-2024038089-A1 USE OF A THERAPEUTIC AGENT WITH PHOSPHODIESTERASE-7 INHIBITORY ACTIVITY FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH CHRONIC FATIGUE, EXHAUSTION AND/OR EXERTIONAL INTOLERANCE MITODICURE GMBH (DE) 2024-02-22 WO disclosed